Literature DB >> 33407574

Health provider perspectives on the implementation of the same-day-ART initiation policy in the Gauteng province of South Africa.

Dorina Onoya1, Idah Mokhele2, Tembeka Sineke2, Bulelwa Mngoma3, Aneesa Moolla2, Marnie Vujovic3, Jacob Bor2,4,5, Jonas Langa3, Matthew P Fox2,4,5.   

Abstract

BACKGROUND: In September 2016, South Africa (SA) began implementing the universal-test-and-treat (UTT) policy in hopes of attaining the UNAIDS 90-90-90 targets by 2020. The SA National Department of Health provided a further directive to initiate antiretroviral therapy (ART) on the day of HIV diagnosis in September 2017. We conducted a qualitative study to determine the progress in implementing UTT and examine health providers' perspectives on the implementation of the same-day initiation (SDI) policy, six months after the policy change.
METHODS: We conducted in-depth interviews with three professional nurses, and four HIV lay counsellors of five primary health clinics in the Gauteng province, between October and December 2017. In September 2018, we also conducted a focus group discussion with ten professional nurses/clinic managers from ten clinic facilities. The interviews and focus groups covered the adoption and implementation of UTT and SDI policies. Interviews were conducted in English, Sotho or Zulu and audio-recorded with participant consent. Audio-recordings were transcribed verbatim, translated to English and analysed thematically using NVivo 11.
RESULTS: The data indicates inconsistencies across facilities and incongruities between counsellor and nursing provider perspectives regarding the SDI policy implementation. While nurses highlighted the clinical benefits of early ART initiation, they expressed concerns that immediate ART may be overwhelming for some patients, who may be unprepared and likely to disengage from care soon after the initial acceptance of ART. Accordingly, the SDI implementation was slow due to limited patient demand, provider ambivalence to the policy implementations, as well as challenges with infrastructure and human resources. The process for assessing patient readiness was poorly defined by health providers across facilities, inconsistent and counsellor dependent. Providers were also unclear on how to ensure that patients who defer treatment return for ongoing counselling.
CONCLUSIONS: Our results highlight important gaps in the drive to achieve the ART initiation target and demonstrate the need for further engagement with health care providers around the implementation of same-day ART initiation, particularly with regards to infrastructural/capacity needs and the management of patient readiness for lifelong ART on the day of HIV diagnosis. Additionally, there is a need for improved promotion of the SDI provision both in health care settings and in media communications to increase patient demand for early and lifelong ART.

Entities:  

Keywords:  ART attrition; HIV; Health provider; Same-day ART; Universal-test-and-treat

Year:  2021        PMID: 33407574     DOI: 10.1186/s12961-020-00673-y

Source DB:  PubMed          Journal:  Health Res Policy Syst        ISSN: 1478-4505


  39 in total

1.  Adolescence: a foundation for future health.

Authors:  Susan M Sawyer; Rima A Afifi; Linda H Bearinger; Sarah-Jayne Blakemore; Bruce Dick; Alex C Ezeh; George C Patton
Journal:  Lancet       Date:  2012-04-25       Impact factor: 79.321

Review 2.  Clinical uncertainties, health service challenges, and ethical complexities of HIV "test-and-treat": a systematic review.

Authors:  Sonali P Kulkarni; Kavita R Shah; Karthik V Sarma; Anish P Mahajan
Journal:  Am J Public Health       Date:  2013-04-18       Impact factor: 9.308

3.  Critical considerations for adopting the HIV 'treat all' approach in Zimbabwe: is the nation poised?

Authors:  K C Takarinda; A D Harries; T Mutasa-Apollo
Journal:  Public Health Action       Date:  2016-02-11

Review 4.  The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon?

Authors:  Maria Lahuerta; Frances Ue; Susie Hoffman; Batya Elul; Sarah Gorrell Kulkarni; Yingfeng Wu; Harriet Nuwagaba-Biribonwoha; Robert H Remien; Wafaa El Sadr; Denis Nash
Journal:  J Health Care Poor Underserved       Date:  2013-02

5.  Antiretroviral Therapy for the Prevention of HIV-1 Transmission.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Leslie Cottle; Xinyi C Zhang; Joseph Makhema; Lisa A Mills; Ravindre Panchia; Sharlaa Faesen; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David D Celentano; Max Essex; Sarah E Hudelson; Andrew D Redd; Thomas R Fleming
Journal:  N Engl J Med       Date:  2016-07-18       Impact factor: 91.245

6.  Clinical outcome of children on HAART at police referral hospital, Addis Ababa, Ethiopia.

Authors:  Solomon Tessema Memirie
Journal:  Ethiop Med J       Date:  2009-01

Review 7.  Community views: balancing the public health benefits of earlier antiretroviral treatment with the implications for individual patients - perspectives from the community.

Authors:  Simon Collins; Nathan Geffen
Journal:  Curr Opin HIV AIDS       Date:  2014-01       Impact factor: 4.283

8.  The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.

Authors:  Arin Dutta; Catherine Barker; Ashley Kallarakal
Journal:  PLoS Med       Date:  2015-11-24       Impact factor: 11.069

9.  Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.

Authors:  Sylvie Boyer; Collins Iwuji; Andréa Gosset; Camelia Protopopescu; Nonhlanhla Okesola; Mélanie Plazy; Bruno Spire; Joanna Orne-Gliemann; Nuala McGrath; Deenan Pillay; François Dabis; Joseph Larmarange
Journal:  AIDS Care       Date:  2016

10.  Antiretroviral therapy related adverse effects: Can sub-Saharan Africa cope with the new "test and treat" policy of the World Health Organization?

Authors:  Jobert Richie N Nansseu; Jean Joel R Bigna
Journal:  Infect Dis Poverty       Date:  2017-02-15       Impact factor: 4.520

View more
  3 in total

1.  Retention in care and viral suppression after same-day ART initiation: One-year outcomes of the SLATE I and II individually randomized clinical trials in South Africa.

Authors:  Mhairi Maskew; Alana T Brennan; Willem D F Venter; Matthew P Fox; Lungisile Vezi; Sydney Rosen
Journal:  J Int AIDS Soc       Date:  2021-10       Impact factor: 5.396

2.  Challenges to communicating the Undetectable equals Untransmittable (U=U) HIV prevention message: Healthcare provider perspectives.

Authors:  Daniel Grace; Mackenzie Stewart; Ezra Blaque; Heeho Ryu; Praney Anand; Mark Gaspar; Catherine Worthington; Mark Gilbert
Journal:  PLoS One       Date:  2022-07-21       Impact factor: 3.752

Review 3.  Hepatitis B Virus Research in South Africa.

Authors:  Mohube B Maepa; Abdullah Ely; Anna Kramvis; Kristie Bloom; Kubendran Naidoo; Omphile E Simani; Tongai G Maponga; Patrick Arbuthnot
Journal:  Viruses       Date:  2022-08-31       Impact factor: 5.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.